Literature DB >> 9122179

Sequence requirements of the HIV-1 protease flap region determined by saturation mutagenesis and kinetic analysis of flap mutants.

W Shao1, L Everitt, M Manchester, D D Loeb, C A Hutchison, R Swanstrom.   

Abstract

The retroviral proteases (PRs) have a structural feature called the flap, which consists of a short anti-parallel beta-sheet with a turn. The flap extends over the substrate binding cleft and must be flexible to allow entry and exit of the polypeptide substrates and products. We analyzed the sequence requirements of the amino acids within the flap region (positions 46-56) of the HIV-1 PR. The phenotypes of 131 substitution mutants were determined using a bacterial expression system. Four of the mutant PRs with mutations in different regions of the flap were selected for kinetic analysis. Our phenotypic analysis, considered in the context of published structures of the HIV-1 PR with a bound substrate analogs, shows that: (i) Met-46 and Phe-53 participate in hydrophobic interactions on the solvent-exposed face of the flap; (ii) Ile-47, Ile-54, and Val-56 participate in hydrophobic interactions on the inner face of the flap; (iii) Ile-50 has hydrophobic interactions at the distance of both the delta and gamma carbons; (iv) the three glycine residues in the beta-turn of the flap are virtually intolerant of substitutions. Among these mutant PRs, we have identified changes in both kcat and Km. These results establish the nature of the side chain requirements at each position in the flap and document a role for the flap in both substrate binding and catalysis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9122179      PMCID: PMC20072          DOI: 10.1073/pnas.94.6.2243

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  In vivo mutational analysis of the DNA binding domain of the tissue-specific transcription factor, Pit-1.

Authors:  J Liang; S Moye-Rowley; R A Maurer
Journal:  J Biol Chem       Date:  1995-10-27       Impact factor: 5.157

2.  Structural evidence for gene duplication in the evolution of the acid proteases.

Authors:  J Tang; M N James; I N Hsu; J A Jenkins; T L Blundell
Journal:  Nature       Date:  1978-02-16       Impact factor: 49.962

3.  Complete nucleotide sequences of functional clones of the AIDS virus.

Authors:  L Ratner; A Fisher; L L Jagodzinski; H Mitsuya; R S Liou; R C Gallo; F Wong-Staal
Journal:  AIDS Res Hum Retroviruses       Date:  1987       Impact factor: 2.205

4.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  Conversion from farnesyl diphosphate synthase to geranylgeranyl diphosphate synthase by random chemical mutagenesis.

Authors:  S Ohnuma; T Nakazawa; H Hemmi; A M Hallberg; T Koyama; K Ogura; T Nishino
Journal:  J Biol Chem       Date:  1996-04-26       Impact factor: 5.157

6.  The kinetics of reversible tight-binding inhibition.

Authors:  J W Williams; J F Morrison
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

7.  Structure of a G-protein-coupling domain of a muscarinic receptor predicted by random saturation mutagenesis.

Authors:  D Hill-Eubanks; E S Burstein; T A Spalding; H Bräuner-Osborne; M R Brann
Journal:  J Biol Chem       Date:  1996-02-09       Impact factor: 5.157

8.  A complete library of point substitution mutations in the glucocorticoid response element of mouse mammary tumor virus.

Authors:  C A Hutchison; S K Nordeen; K Vogt; M H Edgell
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

9.  Identification of strong modifications in cation selectivity in an Arabidopsis inward rectifying potassium channel by mutant selection in yeast.

Authors:  N Uozumi; W Gassmann; Y Cao; J I Schroeder
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

10.  Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli.

Authors:  W G Farmerie; D D Loeb; N C Casavant; C A Hutchison; M H Edgell; R Swanstrom
Journal:  Science       Date:  1987-04-17       Impact factor: 47.728

View more
  25 in total

1.  Drug resistance mutations can effect dimer stability of HIV-1 protease at neutral pH.

Authors:  D Xie; S Gulnik; E Gustchina; B Yu; W Shao; W Qoronfleh; A Nathan; J W Erickson
Journal:  Protein Sci       Date:  1999-08       Impact factor: 6.725

2.  Potent antiviral HIV-1 protease inhibitor GRL-02031 adapts to the structures of drug resistant mutants with its P1'-pyrrolidinone ring.

Authors:  Yu-Chung E Chang; XiaXia Yu; Ying Zhang; Yunfeng Tie; Yuan-Fang Wang; Sofiya Yashchuk; Arun K Ghosh; Robert W Harrison; Irene T Weber
Journal:  J Med Chem       Date:  2012-03-22       Impact factor: 7.446

3.  A solution NMR study of the binding kinetics and the internal dynamics of an HIV-1 protease-substrate complex.

Authors:  Etsuko Katoh; John M Louis; Toshimasa Yamazaki; Angela M Gronenborn; Dennis A Torchia; Rieko Ishima
Journal:  Protein Sci       Date:  2003-07       Impact factor: 6.725

4.  Spin labeling and Double Electron-Electron Resonance (DEER) to Deconstruct Conformational Ensembles of HIV Protease.

Authors:  Thomas M Casey; Gail E Fanucci
Journal:  Methods Enzymol       Date:  2015-09-01       Impact factor: 1.600

5.  The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors.

Authors:  Robert W Shafer; Rami Kantor; Matthew J Gonzales
Journal:  AIDS Rev       Date:  2000       Impact factor: 2.500

6.  Effect of flap mutations on structure of HIV-1 protease and inhibition by saquinavir and darunavir.

Authors:  Fengling Liu; Andrey Y Kovalevsky; Yunfeng Tie; Arun K Ghosh; Robert W Harrison; Irene T Weber
Journal:  J Mol Biol       Date:  2008-07-01       Impact factor: 5.469

7.  Intensity of deoxycytidine deamination of HIV-1 proviral DNA by the retroviral restriction factor APOBEC3G is mediated by the noncatalytic domain.

Authors:  Yuqing Feng; Linda Chelico
Journal:  J Biol Chem       Date:  2011-02-07       Impact factor: 5.157

8.  Alteration of substrate and inhibitor specificity of feline immunodeficiency virus protease.

Authors:  Y C Lin; Z Beck; T Lee; V D Le; G M Morris; A J Olson; C H Wong; J H Elder
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

9.  Investigation on the mechanism for the binding and drug resistance of wild type and mutations of G86 residue in HIV-1 protease complexed with Darunavir by molecular dynamic simulation and free energy calculation.

Authors:  Dan Li; Ying Zhang; Run-Ning Zhao; Song Fan; Ju-Guang Han
Journal:  J Mol Model       Date:  2014-02-14       Impact factor: 1.810

10.  Cooperative effects of drug-resistance mutations in the flap region of HIV-1 protease.

Authors:  Jennifer E Foulkes-Murzycki; Christina Rosi; Nese Kurt Yilmaz; Robert W Shafer; Celia A Schiffer
Journal:  ACS Chem Biol       Date:  2012-12-27       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.